本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Solid Biosciences

5.03
+0.16003.29%
盘后4.91-0.1195-2.38%16:54 EDT
成交量:70.23万
成交额:352.05万
市值:3.90亿
市盈率:-1.72
高:5.13
开:4.97
低:4.85
收:4.87
数据加载中...
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2023/01/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/09

重要事件披露

8-K - Current report
2022/12/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

重要事件披露

8-K - Current report
2022/12/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/27

重要事件披露

8-K - Current report
2022/10/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/30

重要事件披露

8-K - Current report
2022/09/30

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership